Bacterial Burden in Critically Injured Ventilated Patients Does Not Correlate with Progression to Pneumonia

被引:8
|
作者
Dennis, Bradley M. [1 ]
Betzold, Richard D. [1 ]
Patton, Daryl [1 ]
Hopper, Herbert A. [1 ]
Jenkins, Judith [1 ]
Fonnesbeck, Chris [2 ]
Drake, Wonder [3 ]
May, Addison K. [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Div Trauma & Surg Crit Care, 404 Med Arts Bldg,211 21st Ave S, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA
[3] Vanderbilt Univ, Med Ctr, Div Pathol Microbiol & Immunol, Nashville, TN USA
基金
美国国家卫生研究院;
关键词
NOSOCOMIAL PNEUMONIA; CARE; PREVENTION; GUIDELINES; MANAGEMENT; MORTALITY; DIAGNOSIS; TRAUMA;
D O I
10.1089/sur.2017.199
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Ventilator-associated pneumonia (VAP) is common in critically injured patients. The pathogenesis of VAP is not completely understood. We hypothesized that mechanically ventilated trauma patients who develop pneumonia have a progressive increase in pathogen burden over the course of ventilation until a threshold for symptomatic pneumonia is reached, leading to clinical suspicion of VAP. Methods: Critically injured adults ventilated for more than two successive days were enrolled. Patients underwent daily surveillance mini-bronchoscopic alveolar lavage (mBAL) while ventilated for 14 days or until extubation. Standard semi-quantitative cultures were performed, and the investigators were blinded to the results. Standard patient management was performed by the clinical team. Patients suspected of having VAP by the clinical team underwent bronchoscopic bronchoalveolar lavage (bBAL) and semi-quantitative culture, with VAP defined as clinical symptoms plus >10(4) colony-forming units (CFU) of bacteria. Standard statistical analysis for non-parametric data was performed. Results: The 37 patients enrolled were ventilated for a median of nine days. While ventilated, 23 patients met the criteria for a clinical suspicion of VAP, of which two were too ill for bronchoscopy. Thus, 21 patients underwent bBALs because of a suspicion of VAP, and 13 (35%) were positive, with >10(4) CFU of one or more pathogens, and were treated for pneumonia. The bacterial burden on mBAL remained <10(4) CFU during ventilation for 32% of patients. None developed clinical symptoms of VAP. Two-thirds (67%) had an mBAL bacterial burden of >10(4) CFU without clinical suspicion of VAP. Half (56%) of positive surveillance cultures were followed by clinical VAP, confirmed by bBAL, all of which had identical pathogens on mBAL and bBAL. Almost half (44%) of the patients with positive surveillance mBALs never developed clinical VAP. Conclusion: A significant percentage of critically injured, ventilated adults develop high bacterial burdens in the lungs early in their course, and many clear these bacteria without developing VAP. Further study is needed to identify the factors causing progression to VAP.
引用
收藏
页码:369 / 375
页数:7
相关论文
共 29 条
  • [21] Effects of three approaches to standardized oral hygiene to reduce bacterial colonization and ventilator associated pneumonia in mechanically ventilated patients: A randomised control trial
    Berry, A. M.
    Davidson, P. M.
    Masters, J.
    Rolls, K.
    Ollerton, R.
    INTERNATIONAL JOURNAL OF NURSING STUDIES, 2011, 48 (06) : 681 - 688
  • [22] Potential Impact of Rapid Multiplex PCR on Antimicrobial Therapy Guidance for Ventilated Hospital-Acquired Pneumonia in Critically III Patients, A Prospective Observational Clinical and Economic Study
    Guillotin, Florian
    Poulain, Cecile
    Gaborit, Benjamin
    Bouras, Marwan
    Cinotti, Raphael
    Lakhal, Karim
    Vourc'h, Mickael
    Rozec, Bertrand
    Asehnoune, Karim
    Vibet, Marie-Anne
    Riche, Valery-Pierre
    Gibaud, Sophie-Anne
    Cremet, Lise
    Roquilly, Antoine
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [23] Does Auscultation of lungs correlate with chest X-ray findings and O2 administered in COVID-19 pneumonia patients ?
    Yadavilli, Rajesh Kumar
    Ibrahim, Kamal
    Al-Asadi, Abbas
    Webster, Ian
    Balmer, Jo
    Ibrahim, Mohammed
    Lomas, Alexander
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [24] Usefulness of 1,3 Beta-D-Glucan Detection in non-HIV Immunocompromised Mechanical Ventilated Critically Ill Patients with ARDS and Suspected Pneumocystis jirovecii Pneumonia
    Lahmer, Tobias
    da Costa, Clarissa Prazeres
    Held, Jurgen
    Rasch, Sebastian
    Ehmer, Ursula
    Schmid, Roland M.
    Huber, Wolfgang
    MYCOPATHOLOGIA, 2017, 182 (7-8) : 701 - 708
  • [25] Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial
    Timsit, Jean-Francois
    Huntington, Jennifer A.
    Wunderink, Richard G.
    Shime, Nobuaki
    Kollef, Marin H.
    Kivistik, Ulo
    Novacek, Martin
    Rea-Neto, Alvaro
    Martin-Loeches, Ignacio
    Yu, Brian
    Jensen, Erin H.
    Butterton, Joan R.
    Wolf, Dominik J.
    Rhee, Elizabeth G.
    Bruno, Christopher J.
    CRITICAL CARE, 2021, 25 (01)
  • [26] Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial
    Jean-François Timsit
    Jennifer A. Huntington
    Richard G. Wunderink
    Nobuaki Shime
    Marin H. Kollef
    Ülo Kivistik
    Martin Nováček
    Álvaro Réa-Neto
    Ignacio Martin-Loeches
    Brian Yu
    Erin H. Jensen
    Joan R. Butterton
    Dominik J. Wolf
    Elizabeth G. Rhee
    Christopher J. Bruno
    Critical Care, 25
  • [27] Burden of pneumonia in patients with viral and bacterial coinfection in Spain during six consecutive influenza seasons, from 2009-10 to 2014-15
    Arias-Fernandez, Loreto
    Montero, Jesus San-Roman
    Gil-Prieto, Ruth
    Walter, Stefan
    de Miguel, Angel Gil
    VACCINE, 2021, 39 (35) : 5002 - 5006
  • [28] Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia
    Martin-Loeches, I.
    Bermejo-Martin, J. F.
    Valles, J.
    Granada, R.
    Vidaur, L.
    Vergara-Serrano, J. C.
    Martin, M.
    Figueira, J. C.
    Sirvent, J. M.
    Blanquer, J.
    Suarez, D.
    Artigas, A.
    Torres, A.
    Diaz, E.
    Rodriguez, A.
    INTENSIVE CARE MEDICINE, 2013, 39 (04) : 693 - 702
  • [29] Diagnosis and Treatment of Bacterial Pneumonia in Critically Ill Patients with COVID-19 Using a Multiplex PCR Assay: A Large Italian Hospital's Five-Month Experience
    Posteraro, Brunella
    Cortazzo, Venere
    Liotti, Flora Marzia
    Menchinelli, Giulia
    Ippoliti, Chiara
    De Angelis, Giulia
    La Sorda, Marilena
    Capalbo, Gennaro
    Vargas, Joel
    Antonelli, Massimo
    Sanguinetti, Maurizio
    De Pascale, Gennaro
    Spanu, Teresa
    MICROBIOLOGY SPECTRUM, 2021, 9 (03):